Advisors Preferred LLC Acquires 53,529 Shares of Owens & Minor, Inc. (NYSE:OMI)

Advisors Preferred LLC lifted its holdings in shares of Owens & Minor, Inc. (NYSE:OMI) by 173.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 84,305 shares of the company’s stock after purchasing an additional 53,529 shares during the period. Advisors Preferred LLC’s holdings in Owens & Minor were worth $1,083,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. Royce & Associates LP increased its stake in Owens & Minor by 179.4% in the 3rd quarter. Royce & Associates LP now owns 80,914 shares of the company’s stock worth $1,270,000 after purchasing an additional 51,955 shares during the period. FMR LLC grew its holdings in Owens & Minor by 0.8% in the 3rd quarter. FMR LLC now owns 11,564,624 shares of the company’s stock worth $181,449,000 after acquiring an additional 90,862 shares during the last quarter. Waldron Private Wealth LLC purchased a new position in shares of Owens & Minor in the fourth quarter valued at about $406,000. JPMorgan Chase & Co. raised its stake in shares of Owens & Minor by 68.4% during the third quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock valued at $5,912,000 after acquiring an additional 152,999 shares during the last quarter. Finally, Foundry Partners LLC purchased a new stake in shares of Owens & Minor during the third quarter worth about $5,238,000. 98.04% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on OMI shares. Barclays decreased their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a report on Tuesday, November 5th. Robert W. Baird dropped their target price on shares of Owens & Minor from $15.00 to $14.00 and set a “neutral” rating on the stock in a report on Tuesday. Citigroup lowered their price target on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Finally, UBS Group lowered their price objective on Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Owens & Minor presently has an average rating of “Hold” and a consensus price target of $18.50.

Owens & Minor Stock Up 0.0 %

Shares of Owens & Minor stock opened at $8.65 on Friday. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. Owens & Minor, Inc. has a 52 week low of $8.43 and a 52 week high of $28.35. The stock’s 50-day simple moving average is $13.41 and its 200-day simple moving average is $14.12.

Insider Activity

In related news, CFO Jonathan A. Leon sold 5,282 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the sale, the chief financial officer now directly owns 130,822 shares in the company, valued at approximately $1,546,316.04. The trade was a 3.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 3.59% of the company’s stock.

Owens & Minor Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.